\
&
Contact us
\
&
Contact us
Published on | 1 year ago
Programmes Defence EDF NATO-EDA SpaceProjects, partners, priorities and procurements – In 2023 EDA reinforced its contribution to European defence
In the Agency’s annual report for 2023, they provide an overview of EDA’s milestones reached and achievements over the year. Highlights include:
🔹Denmark joining as EDA’s 27th member
🔹Deepening ties with the U.S. Department of Defence through an Administrative Arrangement
🔹Agreeing the 2023 Capability Development Priorities
🔹Stepping up in 2023 with EDA’s two-year fast-track procedure for the joint procurement of 155mm artillery rounds
🔹Transferring EDA’s long-running helicopter programme to a new centre in Portugal
🔹Achieving Initial Operational Capability for the multinational fleet of Airbus A330 tanker and transport aircraft, a project established by EDA
Overall, in 2023, the Agency managed around 94 cooperative ad-hoc projects and programmes in capability development, training, and joint procurement, as well as Research and Technology (R&T) and innovation, with a total estimated value in the range of €664 million.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.
